Navigation Links
The ASDS Introduces the First At-Home Skin Cancer Exam Kit
Date:4/21/2009

Kit offered on new Facebook site to help raise awareness of deadliest form of skin cancer

ROLLING MEADOWS, Ill., April 21 /PRNewswire-USNewswire/ -- In recognition of Skin Cancer Awareness Month and the increasing incidence of skin cancer in the United States, the American Society for Dermatologic Surgery (ASDS) has created a free Skin Self Exam (SSE) kit available on the Society's Facebook site. The kit and site were created to educate younger audiences about the potential dangers of skin cancer and the importance of early detection methods.

"Melanoma is the deadliest form of skin cancer and is the second most common cancer affecting women aged 20 to 29," says Robert Weiss, M.D., president of the ASDS. "The 5-year survival rate for people whose melanoma is detected and treated before it spreads is 99 percent; therefore, it's critical that consumers perform regular self-skin exams. Through Facebook, the ASDS is pleased to provide young women and men who are at highest risk for skin cancer with resources that could potentially save their lives."

The ASDS' SSE kit includes instructions on how to properly monitor and measure suspicious moles and other lesions. The kit, available on the ASDS' Facebook site, Almost 100%, provides consumers with statistics and background information about skin cancer, instructions for completing a thorough self-skin exam, and examples of what to look for when monitoring moles and freckles for the ABCDE's of melanoma: asymmetry, border irregularity, color variation, diameter, and evolving (changes to a mole's size or coloring). To track mole locations and changes to the skin, the ASDS has provided consumers with a 12-month journal, which includes a diagram of the body.

Almost 100% represents the important message that skin cancer is almost 100 percent curable when annual skin cancer screenings are performed by a dermatologic surgeon and the cance
'/>"/>

SOURCE American Society for Dermatologic Surgery
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 2Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 1OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 2OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 3OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 4OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 5Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 1Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 2Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 3